Cargando…

An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh

PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We reviewed 1,103 individual medical device reports submitted to the MAUDE database that...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandberg, Jason M., Gray, Ian, Pearlman, Amy, Terlecki, Ryan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840117/
https://www.ncbi.nlm.nih.gov/pubmed/29520389
http://dx.doi.org/10.4111/icu.2018.59.2.126
_version_ 1783304509497278464
author Sandberg, Jason M.
Gray, Ian
Pearlman, Amy
Terlecki, Ryan P.
author_facet Sandberg, Jason M.
Gray, Ian
Pearlman, Amy
Terlecki, Ryan P.
author_sort Sandberg, Jason M.
collection PubMed
description PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We reviewed 1,103 individual medical device reports submitted to the MAUDE database that inspired the United States (US) Food and Drug Administration's 2008 Public Health Notification. Entries were compiled into a categorical database that reported manufacturer, brand, reporter type, report source, and type of adverse event. RESULTS: There were numerous examples of missing, duplicated, and non-standardized entries. Analysis revealed 64 reports with duplicated information, and six reports representing multiple patients. Forty-seven percent of medical device reports did not identify a reporter source. At least 28% of reported devices are no longer on the US market. There was wide variability in the quality and completeness of submitted reports and true adverse event rates could not be accurately calculated because the number of total cases was unknown. CONCLUSIONS: The MAUDE database was limited in its ability to collect, quantify, and standardize real-life adverse events related to transvaginal mesh. While it functions to collect information related to isolated adverse events, systematic limitations of the MAUDE database, that no doubt extend to other medical devices, necessitate the development of new reporting systems. Alternatives are under development, which may allow regulators to more accurately scrutinize the safety profiles of specific medical devices.
format Online
Article
Text
id pubmed-5840117
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-58401172018-03-08 An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh Sandberg, Jason M. Gray, Ian Pearlman, Amy Terlecki, Ryan P. Investig Clin Urol Original Article PURPOSE: To assess the utility of the Manufacturer And User Facility Device Experience (MAUDE) database in objectively capturing adverse events for transvaginal mesh in the United States. MATERIALS AND METHODS: We reviewed 1,103 individual medical device reports submitted to the MAUDE database that inspired the United States (US) Food and Drug Administration's 2008 Public Health Notification. Entries were compiled into a categorical database that reported manufacturer, brand, reporter type, report source, and type of adverse event. RESULTS: There were numerous examples of missing, duplicated, and non-standardized entries. Analysis revealed 64 reports with duplicated information, and six reports representing multiple patients. Forty-seven percent of medical device reports did not identify a reporter source. At least 28% of reported devices are no longer on the US market. There was wide variability in the quality and completeness of submitted reports and true adverse event rates could not be accurately calculated because the number of total cases was unknown. CONCLUSIONS: The MAUDE database was limited in its ability to collect, quantify, and standardize real-life adverse events related to transvaginal mesh. While it functions to collect information related to isolated adverse events, systematic limitations of the MAUDE database, that no doubt extend to other medical devices, necessitate the development of new reporting systems. Alternatives are under development, which may allow regulators to more accurately scrutinize the safety profiles of specific medical devices. The Korean Urological Association 2018-03 2018-01-29 /pmc/articles/PMC5840117/ /pubmed/29520389 http://dx.doi.org/10.4111/icu.2018.59.2.126 Text en © The Korean Urological Association, 2018 http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sandberg, Jason M.
Gray, Ian
Pearlman, Amy
Terlecki, Ryan P.
An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
title An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
title_full An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
title_fullStr An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
title_full_unstemmed An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
title_short An evaluation of the Manufacturer And User Facility Device Experience database that inspired the United States Food and Drug Administration's Reclassification of transvaginal mesh
title_sort evaluation of the manufacturer and user facility device experience database that inspired the united states food and drug administration's reclassification of transvaginal mesh
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840117/
https://www.ncbi.nlm.nih.gov/pubmed/29520389
http://dx.doi.org/10.4111/icu.2018.59.2.126
work_keys_str_mv AT sandbergjasonm anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT grayian anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT pearlmanamy anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT terleckiryanp anevaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT sandbergjasonm evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT grayian evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT pearlmanamy evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh
AT terleckiryanp evaluationofthemanufactureranduserfacilitydeviceexperiencedatabasethatinspiredtheunitedstatesfoodanddrugadministrationsreclassificationoftransvaginalmesh